Cancer is a complex and multifaceted condition, and its relationship to adaptation and survival in the context of human evolution is a fascinating area of study. At its core, cancer involves the uncontrolled growth and proliferation of cells that acquire mutations, many of which provide them with a survival advantage in specific environmental conditions. To explain how cancer, despite being life-threatening, could be seen as a form of adaptation and how the body’s evolutionary path plays into it, we need to explore biochemical, biophysical, and cellular biological aspects.

Biochemical and Biophysical Aspects: Evolutionary Context

1. Cellular Mutation as Evolutionary Mechanism:

   • At the most basic level, cancer is caused by mutations that affect the regulation of cell growth and death. These mutations are often a result of environmental stressors, such as UV radiation, chemicals, toxins, or oxidative stress. From an evolutionary standpoint, mutation is a natural and essential part of genetic diversity and the adaptation process. In the context of cancer, these mutations can sometimes provide a cellular survival advantage, allowing the cells to thrive in challenging or adverse conditions that would normally kill or damage other cells.

   • The accumulation of mutations in oncogenes (genes that promote cell division) and tumour suppressor genes (genes that inhibit cell division) leads to the unchecked proliferation of cancer cells. From an evolutionary perspective, this could be seen as a response to selective pressures that favour cells that can survive in hostile environments, even though this process ultimately leads to pathological growth.

2. Adaptation to Harsh Environments:

   • Cancer cells exhibit a high degree of adaptability to various stressors such as low oxygen levels (hypoxia), low nutrient availability, and extreme acidity. These stressors often occur in tumors due to their rapid growth, outpacing the development of blood vessels (a process known as angiogenesis).

   • Cancer cells are capable of thriving in hypoxic conditions by upregulating pathways like the hypoxia-inducible factor (HIF), which helps them adapt to low oxygen by activating genes that promote angiogenesis (new blood vessel growth), glycolysis (even without oxygen), and survival mechanisms. This ability to thrive in low-oxygen environments could be considered an adaptive trait that allows cells to continue growing in challenging conditions, potentially reflecting an evolutionary advantage at the cellular level.

3. Metabolic Adaptations (Warburg Effect):

   • One well-known metabolic adaptation in cancer cells is the Warburg effect, where cancer cells shift from oxidative phosphorylation (the efficient way cells produce energy in the presence of oxygen) to anaerobic glycolysis (a less efficient, but faster way of producing ATP). This allows them to generate energy even when oxygen is scarce. The Warburg effect could be seen as an adaptive response to environmental conditions where oxygen or nutrient supply is limited. It’s also a potential biological advantage in situations where tissues face metabolic stress.

Cellular Biological Aspects: Cancer as an Adaptive Process

1. Tumour Heterogeneity:

   • Cancer is not a single disease but rather a collection of related diseases that arise due to mutations in the genetic code of cells. Tumor cells are often highly heterogeneous, meaning they vary significantly in terms of their genetic mutations and behavior. This diversity enables tumor populations to adapt to changing environments. Some cells may be more resistant to chemotherapy, others may better tolerate low oxygen conditions, and some may be better equipped to invade surrounding tissues.

   • From an evolutionary standpoint, this heterogeneity can be seen as a mechanism by which the tumor “evolves” to survive in the face of therapeutic interventions or environmental challenges. It’s like a survival strategy where certain mutant clones within a tumor may thrive while others die off.

2. Cell Death Resistance:

   • Many cancer cells acquire resistance to apoptosis (programmed cell death), which is an essential defense mechanism that eliminates damaged or potentially harmful cells. These mutations can provide a survival advantage, as cells that might normally die off due to damage or stress survive and proliferate. The ability to evade cell death signals could be seen as a form of adaptation in response to environmental pressures, where surviving cells might eventually pass on beneficial mutations to future generations of cells.

3. Increased Proliferation:

   • Cancer cells often exhibit a faster rate of proliferation due to the activation of specific signaling pathways, such as the PI3K-Akt-mTOR pathway and the Ras-Raf-MEK-ERK pathway, both of which are crucial for promoting cell division and survival. This accelerated division allows cancer cells to outcompete normal cells for resources and space, providing them with a potential advantage in the struggle for survival within a challenging environment.

Cancer Cells Thriving in Harsh Environments

1. Oxygen and Nutrient Stress:

   • Cancer cells thrive in environments with limited oxygen (hypoxia) and nutrient supply because they are capable of switching to anaerobic metabolic pathways, as mentioned earlier (Warburg effect). Furthermore, tumor cells secrete signaling molecules like vascular endothelial growth factor (VEGF) to stimulate the growth of new blood vessels (angiogenesis), which helps to ensure a continuous supply of oxygen and nutrients despite being in a low-oxygen, low-nutrient microenvironment.

   • These adaptations enable cancer cells to survive in environments where normal cells would be starved of oxygen or nutrients, providing a significant advantage in rapidly changing or resource-limited environments.

2. Acidity:

   • Tumors are often more acidic than surrounding normal tissues, due to the accumulation of lactic acid from anaerobic glycolysis and poor blood flow. This acidity, while detrimental to normal cells, can be beneficial for cancer cells. Many cancer cells adapt by increasing the expression of ion transporters to regulate the pH and maintain cellular homeostasis under these acidic conditions. This ability to survive and proliferate in acidic environments may reflect an evolutionary advantage for cancer cells in hostile tumour microenvironments.

Biological Signals and Stressors that Promote Cancer Cell Death or Growth Inhibition

1. Hypoxia-Inducible Factors (HIFs):

   • As mentioned, under low-oxygen conditions, cancer cells upregulate the expression of HIFs. HIFs activate various genes involved in angiogenesis, glycolysis, and cell survival. Blocking HIFs is an active area of cancer therapy research, as this could deprive tumors of their ability to adapt to hypoxia and limit their growth potential.

2. Oxidative Stress and DNA Damage:

   • Excessive oxidative stress can damage cellular components like DNA, proteins, and lipids. Cancer cells are often more resistant to oxidative damage than normal cells, but high levels of oxidative stress can eventually overwhelm the antioxidant defense mechanisms, leading to cell death. Therapies that induce oxidative stress are used in some cancer treatments (e.g., chemotherapy and radiation therapy), as these can push the cells past the point of no return, leading to cell death.

3. Nutrient Deprivation and mTOR Inhibition:

   • The mTOR (mechanistic target of rapamycin) pathway is a central regulator of cell growth and metabolism. Under conditions of nutrient deprivation, mTOR is inhibited, which generally leads to cell cycle arrest and activation of autophagy (a process of self-digestion that can provide energy under stress). Inhibiting mTOR in cancer cells can slow their growth and induce cell death. Drugs like rapamycin and targeted mTOR inhibitors are in clinical use for certain types of cancer, demonstrating how nutrient signalling can be leveraged to turn off cancer cell growth.

Conclusion

While cancer is undeniably life-threatening, its cellular and molecular mechanisms can be seen as adaptive responses to environmental pressures, many of which reflect ancient evolutionary strategies for survival. The ability of cancer cells to thrive in hypoxic, nutrient-poor, and acidic environments can be interpreted as a manifestation of the body’s attempt to adapt to harsh conditions. These traits may have conferred an evolutionary advantage in specific, pre-modern environments, but in the modern context, these adaptations lead to disease. In this way, cancer is both a product of the body’s adaptive processes and a pathological manifestation of these same processes gone awry.